(Q34421403)

2 August 2017

1 reference

title

Opioids in cancer and chronic non-cancer pain therapy-indications and controversies (English)

1 reference

2 August 2017

0 references

0 references

Breivik H

1

1 reference

2 August 2017

language of work or name

English

0 references

publication date

1 October 2001

1 reference

Acta Anaesthesiologica Scandinavica

2 August 2017

published in

1 reference

2 August 2017

volume

45

1 reference

2 August 2017

issue

9

1 reference

2 August 2017

page(s)

1059-1066

1 reference

Morphine and alternative opioids in cancer pain: the EAPC recommendations

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-6576.2001.450902.X

Treatment of cancer pain in Norway. A questionnaire study

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-6576.2001.450902.X

Lack of analgesic effect of opioids on neuropathic and idiopathic forms of pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-6576.2001.450902.X

Hyperalgesia and myoclonus in terminal cancer patients treated with continuous intravenous morphine

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-6576.2001.450902.X

Opioid use in cancer pain. Is a more liberal approach enhancing toxicity?

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-6576.2001.450902.X

Mu-opioid receptor desensitization by beta-arrestin-2 determines morphine tolerance but not dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-6576.2001.450902.X

Antagonists of excitatory opioid receptor functions enhance morphine's analgesic potency and attenuate opioid tolerance/dependence liability

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-6576.2001.450902.X

21 January 2018

Methadone in cancer pain

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-6576.2001.450902.X

Methadone, ciprofloxacin, and adverse drug reactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-6576.2001.450902.X

Morphine and oxycodone hydrochloride in the management of cancer pain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-6576.2001.450902.X

Co-administration of sub-antinociceptive doses of oxycodone and morphine produces marked antinociceptive synergy with reduced CNS side-effects in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-6576.2001.450902.X

Adrenaline markedly improves thoracic epidural analgesia produced by a low-dose infusion of bupivacaine, fentanyl and adrenaline after major surgery. A randomised, double-blind, cross-over study with and without adrenaline

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-6576.2001.450902.X

Injection of morphine loco dolenti recommended as early as 1876.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-6576.2001.450902.X

Neuropathic pain: aetiology, symptoms, mechanisms, and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-6576.2001.450902.X

Oral transmucosal fentanyl citrate (OTFC) for the treatment of breakthrough pain in cancer patients: a controlled dose titration study

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-6576.2001.450902.X

Sedation in terminally ill patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-6576.2001.450902.X

Treatment outcome of chronic non-malignant pain patients managed in a danish multidisciplinary pain centre compared to general practice: a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-6576.2001.450902.X

Opioid pseudoaddiction--an iatrogenic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-6576.2001.450902.X

Opioid therapy of chronic pain: assessment of consequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-6576.2001.450902.X

Chronic opioid therapy for nonmalignant pain in patients with a history of substance abuse: report of 20 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-6576.2001.450902.X

Prolonged treatment with transdermal fentanyl in neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-6576.2001.450902.X

Efficacy of oxycodone in neuropathic pain: a randomized trial in postherpetic neuralgia

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-6576.2001.450902.X

Randomised trial of oral morphine for chronic non-cancer pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-6576.2001.450902.X

Management of cancer pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-6576.2001.450902.X

7 January 2021

Opiophobia and cancer pain in Europe

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-6576.2001.450902.X

7 January 2021

Differential effects of epidural morphine in the treatment of cancer-related pain

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-6576.2001.450902.X

7 January 2021

Methadone in cancer pain

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-6576.2001.450902.X

7 January 2021

10.1034/J.1399-6576.2001.450902.X

Identifiers

DOI

1 reference

2 August 2017

1 reference